GCP
ZSAN

GSA Capital Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

GSA Capital Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,044
Closed -$303K – 1959
2021
Q3 		$303K Sell
12,044
-13,094
-52% -$340K 0.03% 1009
2021
Q2 		$836K Buy
25,138
+22,659
+914% +$730K 0.09% 336
2021
Q1 		$108K Sell
2,479
-1,006
-29% -$42.1K 0.02% 995
2020
Q4 		$64K Buy
+3,485
New +$68.1K 0.01% 1129

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

GSA Capital Partners's ZSAN Position: Q4 2021 in Review

GSA Capital Partners sold out of Zosano Pharma Corporation (ZSAN) in Q4 2021, closing a stake of 12,044 shares — an estimated $303K sold.

GSA Capital Partners first reported a position in ZSAN in Q4 2020 and held it in 4 quarters. The position peaked at $836K in Q2 2021. 32 funds tracked by Wall St. Rank hold ZSAN as of Q4 2021.

  • GSA Capital Partners reported no remaining Zosano Pharma Corporation position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 12,044 Zosano Pharma Corporation shares in Q4 2021, an estimated $303K.
  • GSA Capital Partners first reported a position in Zosano Pharma Corporation in Q4 2020 and held it in 4 quarters.
  • GSA Capital Partners's Zosano Pharma Corporation position peaked at $836K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.